Summit Securities Group’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,334
Closed -$19.5K 1501
2025
Q1
$19.5K Buy
+3,334
New +$17.6K ﹤0.01% 470
2016
Q1
Sell
-8,711
Closed -$588K 347
2015
Q4
$588K Buy
+8,711
New +$466K 0.19% 85

Other funds holding NVRO

Summit Securities Group's NVRO Position: Q2 2025 in Review

Summit Securities Group sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 3,334 shares — an estimated $19.5K sold.

Summit Securities Group first reported a position in NVRO in Q4 2015 and held it in 2 quarters. The position peaked at $588K in Q4 2015. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Summit Securities Group reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Summit Securities Group sold 3,334 NEVRO CORP. shares in Q2 2025, an estimated $19.5K.
  • Summit Securities Group first reported a position in NEVRO CORP. in Q4 2015 and held it in 2 quarters.
  • Summit Securities Group's NEVRO CORP. position peaked at $588K in Q4 2015.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Summit Securities Group's 13F filing for Q2 2025, filed 12 Aug 2025.